SupCD7 CAR T

· Institute of Hematology & Blood Diseases Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SupCD7 CAR T, covering 2025-12-15 to 2025-12-15. Get the full timeline:

Most recent: Clinical Trial Update: SupCD7 CART for Relapsed or Refractory CD7 Positive Hematologic Malignancies [Phase 1, Phase 2]